- Home
- UGRO vs PYPD Comparison
UGRO vs PYPD Comparison
Compare UGRO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- PYPD
- Stock Information
- Founded
- UGRO 2014
- PYPD 2008
- Country
- UGRO United States
- PYPD Israel
- Employees
- UGRO N/A
- PYPD N/A
- Industry
- UGRO Industrial Specialties
- PYPD Medical/Dental Instruments
- Sector
- UGRO Consumer Discretionary
- PYPD Health Care
- Exchange
- UGRO Nasdaq
- PYPD Nasdaq
- Market Cap
- UGRO 18.0M
- PYPD 16.5M
- IPO Year
- UGRO N/A
- PYPD 2020
- Fundamental
- Price
- UGRO $1.07
- PYPD $3.22
- Analyst Decision
- UGRO Strong Buy
- PYPD Strong Buy
- Analyst Count
- UGRO 2
- PYPD 2
- Target Price
- UGRO $5.63
- PYPD $12.00
- AVG Volume (30 Days)
- UGRO 55.7K
- PYPD 29.2K
- Earning Date
- UGRO 12-27-2024
- PYPD 02-12-2025
- Dividend Yield
- UGRO N/A
- PYPD N/A
- EPS Growth
- UGRO N/A
- PYPD N/A
- EPS
- UGRO N/A
- PYPD N/A
- Revenue
- UGRO $70,320,066.00
- PYPD N/A
- Revenue This Year
- UGRO $14.76
- PYPD N/A
- Revenue Next Year
- UGRO $21.29
- PYPD N/A
- P/E Ratio
- UGRO N/A
- PYPD N/A
- Revenue Growth
- UGRO 12.08
- PYPD N/A
- 52 Week Low
- UGRO $0.93
- PYPD $2.37
- 52 Week High
- UGRO $2.84
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- UGRO 33.37
- PYPD 53.21
- Support Level
- UGRO $1.17
- PYPD $2.37
- Resistance Level
- UGRO $1.19
- PYPD $3.13
- Average True Range (ATR)
- UGRO 0.11
- PYPD 0.32
- MACD
- UGRO -0.02
- PYPD 0.05
- Stochastic Oscillator
- UGRO 24.78
- PYPD 64.89
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.